These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression. Shi Y; Wang C; Huang F; Chen Z; Sun Z; Wang J; Tang B; Ashizawa T; Klockgether T; Jiang H Cerebellum; 2015 Dec; 14(6):677-81. PubMed ID: 25869927 [TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance spectroscopy of the cerebellum in patients with spinocerebellar ataxia type 3/Machado-Joseph disease. Lei L; Liao Y; Liao W; Zhou J; Yuan Y; Wang J; Jiang H; Shen L; Tang B Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):511-9. PubMed ID: 21743142 [TBL] [Abstract][Full Text] [Related]
6. Body mass index is inversely correlated with the expanded CAG repeat length in SCA3/MJD patients. Saute JA; Silva AC; Souza GN; Russo AD; Donis KC; Vedolin L; Saraiva-Pereira ML; Portela LV; Jardim LB Cerebellum; 2012 Sep; 11(3):771-4. PubMed ID: 22090366 [TBL] [Abstract][Full Text] [Related]
7. The correlation between magnetic resonance imaging features of the brainstem and cerebellum and clinical features of spinocerebellar ataxia 3/Machado-Joseph disease. Liang X; Jiang H; Chen C; Zhou G; Wang J; Zhang S; Lei L; Wang X; Tang B Neurol India; 2009; 57(5):578-83. PubMed ID: 19934555 [TBL] [Abstract][Full Text] [Related]
8. Related factors of ICARS and SARA scores on spinocerebellar ataxia type 3/Machado-Joseph disease. Zhou J; Lei L; Liao X; Wang J; Jiang H; Tang B; Shen L Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):498-503. PubMed ID: 21743140 [TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of NSE and S100B in spinocerebellar ataxia type 3/Machado-Joseph disease. Zhou J; Lei L; Shi Y; Wang J; Jiang H; Shen L; Tang B Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):504-10. PubMed ID: 21743141 [TBL] [Abstract][Full Text] [Related]
11. Fatigue and Its Associated Factors in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease. Martinez AR; Nunes MB; Faber I; D'Abreu A; Lopes-Cendes Í; França MC Cerebellum; 2017 Feb; 16(1):118-121. PubMed ID: 27021342 [TBL] [Abstract][Full Text] [Related]
12. Progression rate of neurological deficits in a 10-year cohort of SCA3 patients. Jardim LB; Hauser L; Kieling C; Saute JA; Xavier R; Rieder CR; Monte TL; Camey S; Torman VB Cerebellum; 2010 Sep; 9(3):419-28. PubMed ID: 20467850 [TBL] [Abstract][Full Text] [Related]
13. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Dürr A; Stevanin G; Cancel G; Duyckaerts C; Abbas N; Didierjean O; Chneiweiss H; Benomar A; Lyon-Caen O; Julien J; Serdaru M; Penet C; Agid Y; Brice A Ann Neurol; 1996 Apr; 39(4):490-9. PubMed ID: 8619527 [TBL] [Abstract][Full Text] [Related]
14. Age related axonal neuropathy in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD). Klockgether T; Schöls L; Abele M; Bürk K; Topka H; Andres F; Amoiridis G; Lüdtke R; Riess O; Laccone F; Dichgans J J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):222-4. PubMed ID: 10071104 [TBL] [Abstract][Full Text] [Related]